首页> 外文会议>Photonic Therapeutics and Diagnostics II; Progress in Biomedical Optics and Imaging; vol.7, no.1 >Near infrared imaging to identify sentinel lymph nodes in invasive urinary bladder cancer
【24h】

Near infrared imaging to identify sentinel lymph nodes in invasive urinary bladder cancer

机译:近红外成像可识别浸润性膀胱癌的前哨淋巴结

获取原文
获取原文并翻译 | 示例

摘要

Approximately 12,000 people are diagnosed with invasive transitional cell carcinoma of the urinary bladder (InvTCC) each year in the United States. Surgical removal of the bladder (cystectomy) and regional lymph node dissection are considered frontline therapy. Cystectomy causes extensive acute morbidity, and 50% of patients with InvTCC have occult metastases at the time of diagnosis. Better staging procedures for InvTCC are greatly needed. This study was performed to evaluate an intra-operative near infrared fluorescence imaging (NIRF) system (Frangioni laboratory) for identifying sentinel lymph nodes draining InvTCC. NIRF imaging was used to map lymph node drainage from specific quadrants of the urinary bladder in normal dogs and pigs, and to map lymph node drainage from naturally-occurring InvTCC in pet dogs where the disease closely mimics the human condition. Briefly, during surgery NIR fluorophores (human serum albumen-fluorophore complex, or quantum dots) were injected directly into the bladder wall, and fluorescence observed in lymphatics and regional nodes. Conditions studied to optimize the procedure including: type of fluorophore, depth of injection, volume of fluorophore injected, and degree of bladder distention at the time of injection. Optimal imaging occurred with very superficial injection of the fluorophore in the serosal surface of the moderately distended bladder. Considerable variability was noted from dog to dog in the pattern of lymph node drainage. NIR fluorescence was noted in lymph nodes with metastases in dogs with InvTCC. In conclusion, intra-operative NIRF imaging is a promising approach to improve sentinel lymph node mapping in invasive urinary bladder cancer.
机译:在美国,每年大约有12,000人被诊断患有膀胱浸润性移行细胞癌(InvTCC)。手术切除膀胱(膀胱切除术)和局部淋巴结清扫术被认为是一线治疗。膀胱切除术引起广泛的急性发病,在诊断时,有50%的InvTCC患者有隐匿性转移。非常需要更好的InvTCC分期程序。进行这项研究以评估术中近红外荧光成像(NIRF)系统(Frangioni实验室),以识别引流InvTCC的前哨淋巴结。 NIRF成像用于绘制正常犬和猪的膀胱特定象限的淋巴结引流图,并绘制这种疾病与人类状况非常相似的宠物狗中自然发生的InvTCC的淋巴结引流图。简而言之,在手术过程中,将NIR荧光团(人血清白蛋白-荧光团复合物或量子点)直接注入膀胱壁,并在淋巴管和区域淋巴结中观察到荧光。为优化程序而研究的条件包括:荧光团的类型,注射深度,荧光团的注射量以及注射时膀胱的扩张程度。最佳成像是通过在中等程度扩张的膀胱浆膜表面非常浅层地注入荧光团而实现的。犬与犬之间的淋巴结引流模式差异很大。在InvTCC犬的淋巴结转移中发现NIR荧光。总之,术中NIRF成像是改善浸润性膀胱癌前哨淋巴结定位的有前途的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号